Table 1 Comparisons between survivors and non-survivors with coronavirus infection
From: Chinese herbal experience for the 2019 novel coronavirus
Variables | All patients (n = 30) | Survivors (n = 7) | Non-survivors (n = 23) | p |
|---|---|---|---|---|
Gender (male, %) | 19 (63.3) | 7 (100) | 12 (52.1) | 0.029 |
Age (years, %) | 67.4 ± 9.2 | 65.7 ± 9.7 | 67.9 ± 9.2 | 0.582 |
PaO2/FiO2 | 107.7 ± 54.5 | 122.5 ± 52.3 | 102.2 ± 55.6 | 0.410 |
ICU length of stay | 10.5 (5–14) | 12 (10–12) | 10 (4–15) | 0.402 |
Intubation rate (%) | 18 (60.0) | 3 (42.8) | 15 (65.2) | 0.290 |
Comorbidities | ||||
Hypertension (%) | 10 (33.3) | 3 (42.8) | 7 (30.4) | 0.657 |
Diabetes (%) | 7 (23.3) | 1 (14.2) | 6 (26.0) | 1.000 |
Use of Chinese herbal | 0.033 | |||
The whole course (%) | 9 (30) | 5 (71.4) | 4 (17.3) | |
Part of the course (%) | 5 (16.7) | 0 (0) | 5 (21.7) | |
Not used (%) | 16 (53.3) | 2 (28.5) | 14 (60.8) | |